S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
RPID · Rapid Micro Biosystems, Inc. Class A
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
Rapid Micro Biosystems, Inc (RPID)
NASDAQ NMS - GLOBAL MARKET
Life Sciences Tools & Services
$0.82
+0.04
(+5.34%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$0.82
$0.78
$0.82
52-WEEK RANGE
$0.82
$0.76
$4.94
What's happening
- RPID is up 5.34% today, trading at $0.82. — Live quote
- It's trading within 3% of its 52-week low ($0.76). (Finnhub fundamentals)
- Volume today (2,403) is well below its 3-month average of 247,030. (Finnhub fundamentals)
- Reports earnings on 2026-11-05, 14 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $-0.27 actual vs. $-0.25 estimated (-8.8%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 3
Buy 7
Hold 1
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (11 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
RPID
-73.39%
vs S&P 500
-86.17%
1-YEAR RETURN
RPID
-75.42%
vs S&P 500
-89.98%
6-MONTH RETURN
RPID
-65.85%
3-MONTH RETURN
RPID
-63.25%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.27
Est. $-0.25
MISS -8.8%
2026-04-26 (Q1 2026)
$-0.31
Est. $-0.25
MISS -23.2%
2026-01-26 (Q4 2025)
$-0.28
Est. $-0.23
MISS -23.3%
2025-10-26 (Q3 2025)
$-0.26
Est. $-0.25
MISS -4.0%
Valuation Measures & Ratios
Enterprise Value4$45.6M
Forward P/E5—
PEG Ratio6-0.06
Price / Sales (TTM1)1.16
Price / Book74.82
EV4 / Revenue1.30
EV4 / EBITDA—
Profit Margin-145.55%
Operating Margin-141.45%
Return on Equity (ROE8)-177.03%
Return on Assets (ROA9)-73.12%
Avg Volume (3M)247,030
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $82.8M | $105.0M | $147.8M | $150.6M | $113.7M |
| P/E | -1.64 | -2.15 | -3.22 | -3.20 | -2.35 |
| Price/Sales | 2.66 | 3.46 | 4.94 | 5.25 | 4.21 |
| Price/Book | 4.67 | 5.15 | 3.33 | 2.76 | 1.74 |
| EV/Revenue | 2.80 | 3.64 | 4.94 | 4.61 | 3.51 |
| EV/EBITDA | -1.87 | -2.40 | -3.36 | — | — |
| ROE | -284.88% | -239.73% | -103.65% | -86.21% | -74.03% |
| ROA | -86.50% | -78.41% | -54.44% | -62.21% | -56.75% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short853,972
Change from Prior Settlement-9.19%
% of Float—
Days to Cover (Short Ratio)2.28
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 10.9% on the provider's reported measure. Finnhub fundamentals ↗
- Latest SEC filing is Form 10-Q, filed 2026-08-07; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is -145.6%. Finnhub fundamentals ↗
- Trailing 52-week price return is -75.4%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on RPID
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.1M | $8.0M | $7.8M | $7.3M | $7.2M | $7.6M | $6.6M | $5.6M |
| Gross profit | $1.2M | $371.0K | — | $275.0K | $404.0K | — | — | — |
| Operating income | -$12.3M | -$13.9M | -$11.4M | -$12.1M | -$11.7M | -$12.0M | -$13.4M | -$14.3M |
| Net income | -$12.9M | -$14.3M | -$11.5M | -$11.9M | -$11.3M | -$11.3M | -$12.6M | -$13.3M |
| EPS (diluted) | $-0.27 | $-0.31 | $-0.26 | $-0.27 | $-0.26 | $-0.26 | $-0.29 | $-0.31 |
| EPS (basic) | $-0.27 | $-0.31 | $-0.26 | $-0.27 | $-0.26 | $-0.26 | $-0.29 | $-0.31 |
| Operating margin | -$153 | -$173 | -$145 | -$167 | -$162 | -$158 | -$202 | -$254 |
| Net margin | -$160 | -$178 | -$147 | -$163 | -$156 | -$149 | -$190 | -$237 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $58.5M | $62.4M | $74.9M | $84.4M | $75.6M | $85.4M | $98.2M | $105.8M |
| Total liabilities | $40.7M | $42.0M | $41.6M | $40.1M | $21.0M | $19.9M | $22.8M | $21.5M |
| Stockholders' equity | $17.7M | $20.4M | $33.2M | $44.3M | $54.5M | $65.5M | $75.4M | $84.4M |
| Total current assets | $46.3M | $49.2M | $61.2M | $70.0M | $60.1M | $69.2M | $80.9M | $87.9M |
| Total current liabilities | $18.1M | $19.1M | $18.5M | $16.5M | $16.4M | $15.0M | $17.6M | $15.9M |
| Cash & equivalents | $14.7M | $13.8M | $20.0M | $18.9M | $18.3M | $18.9M | $16.9M | $22.0M |
| Marketable securities (current) | — | — | — | — | — | — | — | — |
| Accounts receivable | $5.5M | $6.4M | $3.1M | $5.4M | $6.0M | $4.5M | $7.5M | $3.7M |
| Inventory | $18.9M | $17.4M | $17.6M | $21.1M | $20.6M | $20.7M | $20.2M | $21.3M |
| Other current assets | $706.0K | $823.0K | $734.0K | $621.0K | $756.0K | $1.1M | $843.0K | $751.0K |
| Marketable securities (non-current) | — | — | — | — | — | — | — | — |
| Property, plant & equipment | $8.2M | $8.8M | $9.0M | $9.6M | $10.2M | $10.6M | $11.2M | $11.6M |
| Other non-current assets | $178.0K | $245.0K | $319.0K | $211.0K | $311.0K | $421.0K | $531.0K | $642.0K |
| Accounts payable | $5.2M | $4.7M | $4.1M | $3.6M | $3.3M | $2.6M | $2.5M | $2.3M |
| Accrued liabilities | $6.1M | $6.5M | $8.3M | $6.6M | $5.7M | $5.0M | $7.2M | $7.0M |
| Deferred revenue (current) | $5.5M | $6.6M | $4.7M | $5.1M | $6.1M | $6.1M | $6.6M | $5.4M |
| Other current liabilities | — | — | — | — | — | — | — | — |
| Long-term debt | $19.1M | $19.1M | $18.9M | $18.8M | — | — | $0 | — |
| Other non-current liabilities | $348.0K | $340.0K | $397.0K | $340.0K | $314.0K | $306.0K | $298.0K | $289.0K |
| Retained earnings | -$549.6M | -$536.7M | -$522.4M | -$509.9M | -$498.4M | -$486.5M | -$475.3M | -$465.6M |
| Accumulated other comprehensive income (loss) | -$1.0K | -$1.0K | $11.0K | $12.0K | -$2.0K | $13.0K | $39.0K | $83.0K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$12.7M | -$15.1M | -$3.2M | -$9.1M | -$9.7M | -$9.1M | -$9.9M | -$8.6M |
| Investing cash flow | $4.2M | $8.6M | $3.9M | -$9.6M | $9.3M | $10.7M | $4.9M | -$6.5M |
| Financing cash flow | $9.4M | $247.0K | $443.0K | $19.2M | -$298.0K | $379.0K | -$6.0K | $61.0K |
| Free cash flow | -$12.5M | -$15.5M | -$3.3M | -$9.1M | -$10.1M | -$9.4M | -$10.0M | -$8.8M |
| Capital expenditures | -$223.0K | $394.0K | $92.0K | $73.0K | $366.0K | $319.0K | $98.0K | $223.0K |
| Depreciation & amortization | $674.0K | $706.0K | $790.0K | $804.0K | $811.0K | $847.0K | $869.0K | $859.0K |
| Share-based compensation | $1.3M | $1.2M | $627.0K | $1.1M | $1.2M | $1.0M | $689.0K | $929.0K |
| Deferred income taxes | — | — | $11.4M | — | — | — | $11.5M | — |
| Change in accounts receivable | -$852.0K | $3.2M | -$2.3M | -$618.0K | $1.5M | -$3.0M | $3.8M | -$1.3M |
| Change in inventory | $1.8M | -$144.0K | -$3.1M | $514.0K | $44.0K | $1.1M | -$1.1M | -$176.0K |
| Change in accounts payable | $408.0K | $530.0K | $549.0K | $251.0K | $700.0K | $100.0K | $205.0K | $150.0K |
| Purchases of investments | $2.0M | $3.0M | $4.0M | $20.8M | $2.3M | $0 | $5.5M | $25.1M |
| Sales/maturities of investments | $3.0M | $2.0M | $0 | $2.5M | $0 | $0 | $0 | $4.0M |
| Debt issued | — | — | $0 | $20.0M | — | — | $0 | $0 |
| Debt repaid | — | — | — | — | — | — | — | — |
| Tax withholding on stock comp | $0 | — | $0 | $1.0K | $418.0K | — | $0 | $0 |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $33.6M | $28.1M | $22.5M | $17.1M | $23.2M |
| Operating income | -$47.4M | -$49.9M | -$56.6M | -$63.2M | -$47.2M |
| Net income | -$47.1M | -$46.9M | -$52.5M | -$60.8M | -$73.5M |
| EPS (diluted) | $-1.05 | $-1.08 | $-1.22 | $-1.43 | $-3.94 |
| EPS (basic) | $-1.05 | $-1.08 | $-1.22 | $-1.43 | $-3.94 |
| Operating margin | -$141 | -$178 | -$251 | -$369 | -$203 |
| Net margin | -$140 | -$167 | -$233 | -$355 | -$316 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $74.9M | $98.2M | $143.5M | $190.7M | $241.2M |
| Total liabilities | $41.6M | $22.8M | $25.5M | $26.5M | $20.2M |
| Stockholders' equity | $33.2M | $75.4M | $118.0M | $164.2M | $221.0M |
| Total current assets | $61.2M | $80.9M | $120.4M | $138.6M | $218.1M |
| Total current liabilities | $18.5M | $17.6M | $19.0M | $19.1M | $18.2M |
| Cash & equivalents | $20.0M | $16.9M | $24.3M | $27.1M | $178.4M |
| Marketable securities (current) | — | — | — | — | $15.1M |
| Accounts receivable | $3.1M | $7.5M | $5.5M | $5.4M | $5.0M |
| Inventory | $17.6M | $20.2M | $20.0M | $21.2M | $15.7M |
| Other current assets | $854.0K | $843.0K | $577.0K | $705.0K | $440.0K |
| Marketable securities (non-current) | — | — | — | — | $10.0M |
| Property, plant & equipment | $9.0M | $11.2M | $12.8M | $13.8M | $11.3M |
| Other non-current assets | $319.0K | $531.0K | $770.0K | $1.1M | $1.5M |
| Accounts payable | $4.1M | $2.5M | $2.0M | $5.4M | $3.9M |
| Accrued liabilities | $8.3M | $7.2M | $9.9M | $8.2M | $10.9M |
| Deferred revenue (current) | $4.7M | $6.6M | $6.0M | $4.7M | $3.3M |
| Other current liabilities | — | — | — | — | $338.0K |
| Long-term debt | $18.9M | $0 | — | — | — |
| Other non-current liabilities | $397.0K | $298.0K | $263.0K | $229.0K | $1.2M |
| Retained earnings | -$522.4M | -$475.3M | -$428.4M | -$375.9M | -$315.1M |
| Accumulated other comprehensive income (loss) | $11.0K | $39.0K | -$101.0K | -$1.1M | -$16.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$31.1M | -$44.2M | -$45.1M | -$58.5M | -$55.0M |
| Investing cash flow | $14.3M | $36.7M | $42.2M | -$93.5M | -$13.3M |
| Financing cash flow | $19.8M | $203.0K | $149.0K | $693.0K | $216.7M |
| Free cash flow | -$31.9M | -$45.5M | -$46.9M | -$65.3M | -$58.2M |
| Capital expenditures | $850.0K | $1.4M | $1.8M | $6.7M | $3.2M |
| Depreciation & amortization | $3.3M | $3.4M | $3.1M | $2.8M | $1.5M |
| Share-based compensation | $4.0M | $3.9M | $4.8M | $4.0M | $1.8M |
| Deferred income taxes | $11.4M | $11.5M | $12.4M | -$16.2M | $20.0M |
| Change in accounts receivable | -$4.4M | $2.0M | $163.0K | $364.0K | $17.0K |
| Change in inventory | -$1.5M | $335.0K | -$1.2M | $5.8M | $6.8M |
| Change in accounts payable | $1.6M | $562.0K | -$3.5M | $1.5M | -$524.0K |
| Purchases of investments | $27.1M | $35.0M | $62.5M | $179.2M | $25.1M |
| Sales/maturities of investments | $2.5M | $4.0M | $0 | — | — |
| Debt issued | $20.0M | $0 | — | — | — |
| Debt repaid | — | — | — | $0 | $26.2M |
| Tax withholding on stock comp | $419.0K | $0 | — | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding RPID as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-02-09 to 2026-07-24
Recent transactions
- Most recent: Kollender Richard S (Director) — Option exercise of 1,681 shares on 2026-07-24.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)0 sh(0 txns)
Net Shares+0
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Kollender Richard S | Director | Option exercise | 2026-07-24 | 1,681 |
| Spignesi Robert G. Jr. | PRESIDENT AND CEO | Option exercise | 2026-07-22 | 1,402 |
| LOWENSTEIN INESE | Director | Grant / award | 2026-05-29 | 12,787 |
| PEI MELINDA LITHERLAND | Director | Grant / award | 2026-05-29 | 12,787 |
| Malloy Kirk | Director | Grant / award | 2026-05-29 | 12,787 |
| WIRTJES SEAN M | CHIEF FINANCIAL OFFICER | Grant / award | 2026-05-29 | 12,787 |
| Bika Dafni | Director | Grant / award | 2026-05-21 | 19,300 |
| Wilson John J. Addington | CHIEF OPERATING OFFICER | Open market sale | 2026-03-11 | 9,603 |
| RICCIARDI NATALE S | Director | Option exercise | 2026-02-27 | 842 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-07-24 | Kollender Richard S | Director | Option exercise | 1,681 | $0.75 |
| 2026-07-24 | Kollender Richard S | Director | Option exercise | 1,827 | $0.75 |
| 2026-07-22 | Spignesi Robert G. Jr. | PRESIDENT AND CEO | Option exercise | 1,402 | $0.75 |
| 2026-05-29 | LOWENSTEIN INESE | Director | Grant / award | 12,787 | $1.96 |
| 2026-05-29 | PEI MELINDA LITHERLAND | Director | Grant / award | 12,787 | $1.96 |
| 2026-05-29 | Malloy Kirk | Director | Grant / award | 12,787 | $1.96 |
| 2026-05-29 | WIRTJES SEAN M | CHIEF FINANCIAL OFFICER | Grant / award | 12,787 | $1.96 |
| 2026-05-29 | Spignesi Robert G. Jr. | PRESIDENT AND CEO | Grant / award | 12,787 | $1.96 |
| 2026-05-21 | Malloy Kirk | Director | Grant / award | 19,300 | $0.00 |
| 2026-05-21 | LOWENSTEIN INESE | Director | Grant / award | 19,300 | $0.00 |
| 2026-05-21 | PEI MELINDA LITHERLAND | Director | Grant / award | 19,300 | $0.00 |
| 2026-05-21 | Kollender Richard S | Director | Grant / award | 19,300 | $0.00 |
| 2026-05-21 | Bika Dafni | Director | Grant / award | 19,300 | $0.00 |
| 2026-03-11 | Wilson John J. Addington | CHIEF OPERATING OFFICER | Open market sale | 9,603 | $4.32 |
| 2026-03-11 | WIRTJES SEAN M | CHIEF FINANCIAL OFFICER | Open market sale | 7,480 | $4.32 |
| 2026-03-10 | Spignesi Robert G. Jr. | PRESIDENT AND CEO | Open market sale | 17,922 | $4.11 |
| 2026-02-27 | RICCIARDI NATALE S | Director | Option exercise | 842 | $0.75 |
| 2026-02-20 | Wilson John J. Addington | CHIEF OPERATING OFFICER | Open market sale | 5,403 | $3.92 |
| 2026-02-20 | WIRTJES SEAN M | CHIEF FINANCIAL OFFICER | Open market sale | 17,254 | $3.92 |
| 2026-02-19 | Spignesi Robert G. Jr. | PRESIDENT AND CEO | Open market sale | 38,327 | $3.89 |
| 2026-02-11 | Wilson John J. Addington | CHIEF OPERATING OFFICER | Grant / award | 74,000 | $0.00 |
| 2026-02-11 | WIRTJES SEAN M | CHIEF FINANCIAL OFFICER | Grant / award | 97,000 | $0.00 |
| 2026-02-11 | Spignesi Robert G. Jr. | PRESIDENT AND CEO | Grant / award | 264,000 | $0.00 |
| 2026-02-09 | Wilson John J. Addington | CHIEF OPERATING OFFICER | Open market sale | 4,610 | $3.78 |
| 2026-02-09 | WIRTJES SEAN M | CHIEF FINANCIAL OFFICER | Open market sale | 6,027 | $3.78 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 07:02 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-08-07 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-07 | 8-K | 2026-08-07 | View on SEC.gov → |
| 2026-07-24 | 4 | 2026-07-24 | View on SEC.gov → |
| 2026-07-24 | 4 | 2026-07-22 | View on SEC.gov → |
| 2026-06-02 | 4 | 2026-05-29 | View on SEC.gov → |
| 2026-06-02 | 4 | 2026-05-29 | View on SEC.gov → |
| 2026-06-02 | 4 | 2026-05-29 | View on SEC.gov → |
| 2026-06-02 | 4 | 2026-05-29 | View on SEC.gov → |
| 2026-06-02 | 4 | 2026-05-29 | View on SEC.gov → |
| 2026-05-28 | 8-K | 2026-05-21 | View on SEC.gov → |
| 2026-05-26 | 4 | 2026-05-21 | View on SEC.gov → |
| 2026-05-26 | 4 | 2026-05-21 | View on SEC.gov → |
Recent news
Headlines about RPID (Rapid Micro Biosystems, Inc. Class A). Links open the publisher — we don’t host full articles.
-
Rapid Micro Biosystems Stock Price Prediction: Today, Tomorrow, Next Week (RPID)
Traders Union · 2026-10-21 -
Rapid Micro Biosystems to Participate at the PDA Pharmaceutical Microbiology Conference 2026
Yahoo · 2026-10-20 -
RPID Q2 2026 Earnings: Wider-Than-Expected Loss Sends Shares Lower - Annual Financial Report
https://www.dars.gov.et/ · 2026-10-16 -
Rapid Micro Biosystems, Inc. (RPID) Presents at Small-Cap Virtual Conference - Slideshow
Seeking Alpha · 2026-09-24 -
Rapid Micro Biosystems to Participate in Upcoming Investor Conferences
Yahoo Finance · 2026-09-04 -
After Plunging 33.7% in 4 Weeks, Here's Why the Trend Might Reverse for Rapid Micro Biosystems (RPID)
Yahoo Finance · 2026-09-04 -
Down 25.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Rapid Micro Biosystems (RPID)
Yahoo Finance · 2026-08-19 -
Rapid Micro Biosystems (RPID) Q2 2026 Earnings Call Transcript
Yahoo Finance · 2026-08-14
No headlines in this category right now — try “All”.